Samuel Levy, MD
Samuel Levy is a Venture Partner at iXLife Capital. He is the co-founder and President of Allurion Technologies. Prior to iXLife, Dr. Levy served as an advisor at Kurma Partners and as a consultant in the Pharmaceuticals and Medical Products Management Practice at McKinsey & Company. He also served as a business development associate at Ziopharm Oncology. Dr. Levy graduated summa cum laude and Phi Beta Kappa from Yale College with a B.S. in Molecular Biophysics and Biochemistry. He was a Fulbright scholar at the Institut Pasteur, and graduated from Harvard Medical School.
[ Back to Team ]